Should You Buy Rigel Pharmaceuticals, Inc. (RIGL) Stock Friday Morning?

Rigel Pharmaceuticals, Inc. (RIGL) is lower by Friday morning, with the stock declining -3.09% in pre-market trading to 1.57. RIGL's short-term technical score of 54 indicates that the stock has traded more bullishly over the last month than 54% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, Rigel Pharmaceuticals, Inc. ranks higher than 65% of stocks. Rigel Pharmaceuticals, Inc. has risen 20.90% over the past month, closing at $1.14 on July 22. During this period of time, the stock fell as low as $1.14 and as high as $1.76. RIGL has an average analyst recommendation of Buy. The company has an average price target of $2.39.

RIGL has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on RIGL!

See Full RIGL Report

Rigel Pharmaceuticals, Inc. has a Long-Term Technical rank of 37. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 63% of the market scoring higher. In the Biotechnology industry which is number 83 by this metric, RIGL ranks better than 83% of stocks.

Important Dates for Investors in RIGL:

-Rigel Pharmaceuticals, Inc. is set to release earnings on 10/31/2022. Over the last 12 months, the company has reported EPS of $-0.50. -We do not have a set dividend date for Rigel Pharmaceuticals, Inc. at this time. Click Here To Get The Full Report on Rigel Pharmaceuticals, Inc. (RIGL)